title: Hypertension in obesity.
abstract: Hypertension and obesity are major components of the cardiometabolic syndrome and are both on the rise worldwide, with enormous consequences on global health and the economy. The relationship between hypertension and obesity is multifaceted; the etiology is complex and it is not well elucidated. This article, reviews the current knowledge on obesity-related hypertension. Further understanding of the underlying mechanisms of this epidemic will be important in devising future treatment avenues.
authors.affiliation: Department of Internal Medicine, University of Missouri-Columbia School of Medicine, Columbia, MO 65212, USA. romayne1@health.missouri.edu
authors.forename: L Romayne
authors.initials: LR
authors.lastname: Kurukulasuriya
authors.forename: Sameer
authors.initials: S
authors.lastname: Stas
authors.forename: Guido
authors.initials: G
authors.lastname: Lastra
authors.forename: Camila
authors.initials: C
authors.lastname: Manrique
authors.forename: James R
authors.initials: JR
authors.lastname: Sowers
mesh_terms: D017667:Adipocytes / Q000502:physiology; D052242:Adiponectin / Q000502:physiology; D000818:Animals; D006801:Humans; D006973:Hypertension / Q000209:etiology*; D007333:Insulin Resistance; D007668:Kidney / Q000473:pathology / Q000503:physiopathology; D020738:Leptin / Q000502:physiology; D009765:Obesity / Q000150:complications* / Q000503:physiopathology; D012084:Renin-Angiotensin System / Q000502:physiology; D020181:Sleep Apnea, Obstructive / Q000503:physiopathology; D013564:Sympathetic Nervous System / Q000502:physiology
chemical_list: D052242:Adiponectin; D020738:Leptin